Dr. Priyanka Sharma

Assistant Professor-II

Academic Area : Cancer Biology

Amity Institute of Virology and Immunology (AIVI)

  • Qualifications
    Doctoral thesis research on Development of Mineralocorticoid-Receptor Mediated Anticancer Liposomal Delivery System, December 2015
    Received First Class Master of Philosophy in Biotechnology (M.Phil. Biotechnology), 2009

    · Received First Class Master of Science (M.Sc. Biotechnology) 2007

    · Received First Class Bachelor of Science (B. Sc. Medical), 2004
  • Experience
    Postdoctoral research associate, Cancer Immunology, Department of Pathology, University of Pittsburgh, PA, USA May2016-June 2019
  • Current Courses Taught
    Medical Hematology
    Frontiers in Immunology
    Cellular Immunology
    Bioinformatics & IPR
    Cell Biology & Tissue Culture
    Applications of Cell Culture Technology
    Gender, Environment & Sustainability
    Medical Virology
    Translational Immunology
    Transplant Immunology
    Immunology of Infections
    Clinical Microbiology
    Cancer & Immunity
    Foundations of Immunology
    Basic Immunobiology
    Drugs & Vaccine Development
    Food, Nutrition & Hygiene
    Bioresources & Bioprospecting
  • Publications
    18
  • Professional Activities
    Ongoing Project:Mineralocorticoid-receptor targeted Dendritic cell-derived exosomes for anticancer therapy (SERB funded)
    ? Editorial Board member-"Frontiers in Immunology"
    ? Associate member of American Association of Cancer Research (AACR)
    ? Member of American Society of clinical oncology (ASCO)
    ? Member of American Association for Clinical Chemistry (AACC)
    ? Reviewer- “Photodiagnosis & Photodynamic Therapy” Journal
    ? Reviewer- “Journal of Advanced Pharmaceutical Technology & Research”
    ? Reviewer- Springer Nature "HNO Journal"
    ? Reviewer- "Frontiers in Immunology" Journal
    ? Reviewer- "International Journal of Molecular Sciences"
    ? Reviewer- "Cancers"
    ? Reviewer- "Biomembranes"
    ? Guest Editor- Current issues in Molecular Biology (special issue-exosomes in cancer)
  • Other Achievements
    Sharma P, Ludwig S, Muller L, Hong C S, Kirkwood J M, Ferrone S and Whiteside, T L (2018) Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma. Journal of Extracellular Vesicles. 7(1):1435138. Impact factor 25.84
    2. Sharma P, Diergaarde B, Ferrone S, Kirkwood JM, Whiteside T L (2019) Melanoma cell-derived exosomes in plasma of melanoma patients mediate suppression of immune effector cells. Scientific Reports. Impact factor 4.6
    3. Monika Pietrowska, Aneta Zebrowska, Marta Gawin, Lukasz Marczak, Priyanka Sharma, Sujan Mondal, Justyna Mika, Joanna Polanska, Soldano Ferrone, John M Kirkwood, Piotr Widlak, Theresa L Whiteside (2021) Proteomic profile of melanoma cell-derived small extracellular vesicles in patients’ plasma: a potential correlate of melanoma progression. Journal of extracellular vesicles. Impact factor 25.84
    4. Sonja Ludwig, Priyanka Sharma, Petra Wise, Richard Sposto, Deborah Hollingshead, Janette Lamb, Stephan Lang, Muller Fabbri, Theresa L Whiteside.
    mRNA and miRNA Profiles of Exosomes from Cultured Tumor Cells Reveal Biomarkers Specific for HPV16-Positive and HPV16-Negative Head and Neck Cancer. International Journal of Molecular Sciences. 21(22):8570 Impact factor 6.2
    5. Beatrice M. Razzo, Nils Ludwig, Chang-Sook Hong, Priyanka Sharma, Kellsye P. Fabian, Ronald J. Fecek, Walter J. Storkus, Theresa L. Whiteside. Tumor-derived exosomes promote carcinogenesis of murine oral squamous cell carcinoma. Carcinogenesis. Impact Factor 5.334
    6. Ludwig S, Marczak L, Sharma P, Abramowicz A, Gawin M, Widlak P, Whiteside M, Pietrowska M (2019) Proteomes of exosomes from HPV(+) or HPV(-) Head and Neck Cancer cells: differential enrichment in immunoregulatory proteins. Oncoimmunology. Impact factor 7.19
    7. Ludwig S, Sharma P, Theodoraki, MN, Pietrowska M, Lang S, Ferrone S, Whiteside T L, (2018) Molecular and functional characteristics of exosomes produced by HPV+ and HPV neg Head and Neck Cancer cell lines. Frontiers in Oncology.12(8)445. Impact factor 6.244
    8. William Banks, Sharma P, Bullock KM, Hansen KM, Ludwig N and Whiteside TL (2020) Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation. International Journal of Molecular Sciences. 21(12). Impact factor 6.2
    9. Hong C S, Sharma P, Yerneni S, Simms P, Jackson E K, Whiteside T L, Boyiadzis M (2017) Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia. Scientific Reports Nature. 7(1):14684 Impact factor 4.6
    10. Sharma P, Banerjee R and Narayan KP (2016) Mineralocorticoid receptor mediated liposomal delivery system for targeted induction of apoptosis in cancer cells. Biochimica et Biophysica Acta-Biomembranes. 1858(2):415-21 Impact factor 4.09
    11. Sharma P, Banerjee R and Narayan KP (2016) Data for stable formulation of steroid hormone receptor-targeted liposomes for cancer therapeutics. Data in Brief. 7:428-31 Impact factor 1.13
    12. Sharma P, Banerjee R and Narayan KP (2013) Gene Therapy: Potential Use of Liposomes. Int. J. Pharm. Sci. Rev. Res. 23(1): 126-132.
    13. Sharma P, Banerjee R and Narayan KP (2014) Liposomes for controlled drug delivery: drugs of the future. Journal of Pharmacy Research. 8(5), 637-641. Impact factor 2.97
    14. Sharma P, Bharati M R, Dave M, Kapur S and Narayan K P (2014) Comparative analysis of apoptotic activity from extracts of saponin-rich Indian medicinal plants. Journal of Pharmacy Research. 8(12):1779-1784. Impact factor 2.97
    15. Nils Ludwig, Chang-Sook Hong, Sonja Ludwig, Juliana H. Azambuja, Priyanka Sharma, Marie-Nicole Theodoraki, Theresa L. Whiteside. Isolation and Analysis of Tumor-derived Exosomes. Current Protocols in Immunology. Accepted Impact factor 2.91
    16. Hong Chang-Sook, Danet-Desnoyers G, Shan X, Sharma P, Whiteside TL, Boyiadzis M. Human acute myeloid leukemia blast-derived exosomes in patient-derived xenograft mice mediate immune suppression. Experimental Hematology.pii:S0301-472X(19)30918-X. doi: 10.1016/j.exphem.2019.07.005. Impact factor 3.084
    17. Vetsika E-K, Sharma P, Samaras I, Markou A, Georgoulias V, Whiteside TL, Kotsakis A. Small extracellular vesicles in pre-therapy plasma predict clinical outcome in non-small cell lung cancer patients (2021). Cancers. 13(9):2041. Impact factor 6.639
    18. Banks W, Sharma P, Hansen KM, Ludwig N, & Whiteside TL. Characteristics of Exosomes and the Vascular Landscape Regulate Exosome Sequestration by Peripheral Tissues and Brain (2022). International Journal of Molecular Sciences. 23(20): 12513. Impact Factor 6.2
  • Contact Information
    Amity Institute of Virology and Immunology (AIVI)